Q7Z417 (NUFP2_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
April 3, 2013.
Version 80.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Nuclear fragile X mental retardation-interacting protein 2 Alternative name(s): 82 kDa FMRP-interacting protein Short name=82-FIP Cell proliferation-inducing gene 1 protein FMRP-interacting protein 2 | ||||||
| Gene names |
| ||||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||||
| Taxonomic identifier | 9606 [NCBI] | ||||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 695 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Binds RNA. Ref.1 |
| Subunit structure | Interacts with FMRP. Ref.1 |
| Subcellular location | Nucleus. Cytoplasm. Note: Distribution is cell cycle-modulated, being cytoplasmic in the G2/M phase and accumulating in nucleus during the G1 phase. Ref.1 |
| Sequence caution | The sequence BAA92559.1 differs from that shown. Reason: Erroneous initiation. |
Ontologies
| Keywords | |
|---|---|
| Cellular component | Cytoplasm Nucleus |
| Ligand | RNA-binding |
| PTM | Phosphoprotein |
| Technical term | Complete proteome Direct protein sequencing Reference proteome |
| Gene Ontology (GO) | |
| Cellular_component | nucleus Inferred from direct assay Ref.1. Source: HGNC polysomal ribosomeInferred from direct assay Ref.1. Source: HGNC |
| Molecular_function | RNA binding Inferred from direct assay Ref.1. Source: HGNC |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 695 | 695 | Nuclear fragile X mental retardation-interacting protein 2 | PRO_0000245521 | |||||
Regions | |||||||||
| Compositional bias | 12 – 60 | 49 | His-rich | ||||||
| Compositional bias | 373 – 415 | 43 | Ser-rich | ||||||
Amino acid modifications | |||||||||
| Modified residue | 87 | 1 | Phosphothreonine Ref.9 Ref.16 | ||||||
| Modified residue | 112 | 1 | Phosphoserine Ref.13 Ref.16 Ref.18 | ||||||
| Modified residue | 113 | 1 | Phosphoserine Ref.13 | ||||||
| Modified residue | 212 | 1 | Phosphoserine Ref.8 Ref.13 Ref.15 Ref.16 Ref.18 | ||||||
| Modified residue | 214 | 1 | Phosphoserine Ref.13 | ||||||
| Modified residue | 218 | 1 | Phosphotyrosine Ref.13 | ||||||
| Modified residue | 219 | 1 | Phosphothreonine Ref.13 | ||||||
| Modified residue | 220 | 1 | Phosphothreonine Ref.8 Ref.13 | ||||||
| Modified residue | 376 | 1 | Phosphoserine Ref.15 | ||||||
| Modified residue | 571 | 1 | Phosphothreonine Ref.16 | ||||||
| Modified residue | 572 | 1 | Phosphoserine Ref.13 Ref.15 Ref.16 Ref.18 | ||||||
| Modified residue | 629 | 1 | Phosphoserine Ref.5 Ref.13 Ref.15 Ref.16 Ref.18 | ||||||
| Modified residue | 633 | 1 | Phosphothreonine Ref.16 | ||||||
| Modified residue | 637 | 1 | Phosphoserine Ref.13 Ref.15 | ||||||
| Modified residue | 652 | 1 | Phosphoserine Ref.6 Ref.7 Ref.12 Ref.13 Ref.14 Ref.16 Ref.18 | ||||||
| Modified residue | 655 | 1 | Phosphoserine Ref.18 | ||||||
| Modified residue | 692 | 1 | Phosphoserine Ref.13 Ref.16 Ref.18 | ||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "82-FIP, a novel FMRP (fragile X mental retardation protein) interacting protein, shows a cell cycle-dependent intracellular localization." Bardoni B., Castets M., Huot M.-E., Schenck A., Adinolfi S., Corbin F., Pastore A., Khandjian E.W., Mandel J.-L. Hum. Mol. Genet. 12:1689-1698(2003) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 74-92 AND 593-609, FUNCTION, SUBUNIT, SUBCELLULAR LOCATION, INTERACTION WITH FMRP. |
| [2] | Kim J.W. Submitted (FEB-2003) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. |
| [3] | "Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro." Nagase T., Kikuno R., Ishikawa K., Hirosawa M., Ohara O. DNA Res. 7:65-73(2000) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Brain. |
| [4] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Uterus. |
| [5] | Bienvenut W.V., Waridel P., Quadroni M. Submitted (MAR-2009) to UniProtKB Cited for: PROTEIN SEQUENCE OF 92-104; 110-136; 233-269; 331-351; 369-397; 531-563; 571-639; 650-659; 668-677 AND 683-695, PHOSPHORYLATION AT SER-629, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [6] | "Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry." Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M., Peters E.C. Anal. Chem. 76:2763-2772(2004) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-652, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [7] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-652, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [8] | "A probability-based approach for high-throughput protein phosphorylation analysis and site localization." Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P. Nat. Biotechnol. 24:1285-1292(2006) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-212 AND THR-220, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [9] | "Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra." Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D. J. Proteome Res. 6:4150-4162(2007) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-87, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [10] | "ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage." Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J. Science 316:1160-1166(2007) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Embryonic kidney. |
| [11] | "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis." Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III J. Proteome Res. 7:1346-1351(2008) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Cervix carcinoma. |
| [12] | "Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle." Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R., Greff Z., Keri G., Stemmann O., Mann M. Mol. Cell 31:438-448(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-652, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [13] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-112; SER-113; SER-212; SER-214; TYR-218; THR-219; THR-220; SER-572; SER-629; SER-637; SER-652 AND SER-692, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [14] | "Large-scale proteomics analysis of the human kinome." Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G., Mann M., Daub H. Mol. Cell. Proteomics 8:1751-1764(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-652, MASS SPECTROMETRY. |
| [15] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-212; SER-376; SER-572; SER-629 AND SER-637, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [16] | "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis." Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M. Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-87; SER-112; SER-212; THR-571; SER-572; SER-629; THR-633; SER-652 AND SER-692, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [17] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [18] | "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation." Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B. Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-112; SER-212; SER-572; SER-629; SER-652; SER-655 AND SER-692, MASS SPECTROMETRY. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AJ493465 mRNA. Translation: CAD38278.1. AY232289 mRNA. Translation: AAP69984.1. AB037742 mRNA. Translation: BAA92559.1. Different initiation. BC108307 mRNA. Translation: AAI08308.1. |
| IPI | IPI00002349. |
| RefSeq | NP_065823.1. NM_020772.2. |
| UniGene | Hs.462598. |
3D structure databases | |
| ProteinModelPortal | Q7Z417. |
| ModBase | Search... |
Protein-protein interaction databases | |
| DIP | DIP-29023N. |
| IntAct | Q7Z417. 4 interactions. |
| STRING | 9606.ENSP00000225388. |
PTM databases | |
| PhosphoSite | Q7Z417. |
Polymorphism databases | |
| DMDM | 74713454. |
Proteomic databases | |
| PaxDb | Q7Z417. |
| PeptideAtlas | Q7Z417. |
| PRIDE | Q7Z417. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000225388; ENSP00000225388; ENSG00000108256. |
| GeneID | 57532. |
| KEGG | hsa:57532. |
| UCSC | uc002hdy.4. human. |
Organism-specific databases | |
| CTD | 57532. |
| GeneCards | GC17M027582. |
| HGNC | HGNC:17634. NUFIP2. |
| HPA | HPA017344. |
| MIM | 609356. gene. |
| neXtProt | NX_Q7Z417. |
| PharmGKB | PA143485564. |
| HUGE | Search... |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | NOG85203. |
| HOGENOM | HOG000220869. |
| HOVERGEN | HBG065794. |
| InParanoid | Q7Z417. |
| OMA | TKEMESV. |
| OrthoDB | EOG42JNRF. |
Gene expression databases | |
| ArrayExpress | Q7Z417. |
| Bgee | Q7Z417. |
| CleanEx | HS_NUFIP2. |
| Genevestigator | Q7Z417. |
| GermOnline | ENSG00000108256. Homo sapiens. |
Family and domain databases | |
| ProtoNet | Search... |
Other | |
| ChiTaRS | NUFIP2. human. |
| GenomeRNAi | 57532. |
| NextBio | 63940. |
| SOURCE | Search... |
Entry information
| Entry name | NUFP2_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q7Z417 Secondary accession number(s): Q9P2M5 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 17 Human chromosome 17: entries, gene names and cross-references to MIM |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |

Clusters with
